SWOG clinical trial number
SWOG-8944
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma
Closed
Phase
Accrual
48%
Published
Abbreviated Title
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma
Activated
03/01/1990
Closed
06/01/1991
Publication Information Expand/Collapse
1994
Phase II study of carboplatin (CBDCA) in refractory multiple myeloma: A Southwest Oncology Group study.